The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima
Open accessAbstract
The trapping of lipid-laden macrophages in the arterial intima is a critical but reversible step in atherogenesis. However, the mechanism by which this occurs is not clearly defined. Here, we tested in mice the hypothesis that CD36, a class B scavenger receptor expressed on macrophages, has a role in this process. Using both in vivo and in vitro migration assays, we found that oxidized LDL (oxLDL), but not native LDL, inhibited migration of WT mouse macrophages but not CD36-deficient cells. We further observed a crucial role for CD36 in modulating the in vitro migratory response of human peripheral blood monocyte-derived macrophages to oxLDL. oxLDL also induced rapid spreading and actin polymerization in CD36-sufficient but not CD36-deficient mouse macrophages in vitro. The underlying mechanism was dependent on oxLDL-mediated CD36 signaling, which resulted in sustained activation of focal adhesion kinase (FAK) and inactivation of Src homology 2-containing phosphotyrosine phosphatase (SHP-2). The latter was due to NADPH oxidase-mediated ROS generation, resulting in oxidative inactivation of critical cysteine residues in the SHP-2-active site. Macrophage migration in the presence of oxLDL was restored by both antioxidants and NADPH oxidase inhibitors, which restored the dynamic activation of FAK. We conclude therefore that CD36 signaling in response to oxLDL alters cytoskeletal dynamics to enhance macrophage spreading, inhibiting migration. This may induce trapping of macrophages in the arterial intima and promote atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492
Inflammation in Atherosclerosis
Libby, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,736
Vitamin E Consumption and the Risk of Coronary Heart Disease in Men
Rimm, E. B., Stampfer, M. J., Ascherio, A., Giovannucci, E., Colditz, G. A., & Willett, W. C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282004 · Cited by 2,347
CD36 is a receptor for oxidized low density lipoprotein
Endemann, G., Stanton, L. W., Madden, K. S., Bryant, C. M., White, R. T., & Protter, A. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50272-1 · Cited by 1,281
HATCH, F. T., & LEES, R. S. (1968) · Advances in Lipid Research · doi:10.1016/b978-1-4831-9942-9.50008-5 · Cited by 1,234
Febbraio, M., Hajjar, D. P., & Silverstein, R. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14006 · Cited by 1,193
Self-citationFebbraio, M., Podrez, E. A., Smith, J. D., Hajjar, D. P., Hazen, S. L., Hoff, H. F., Sharma, K., & Silverstein, R. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9259 · Cited by 1,044
Self-citationReversible oxidation and inactivation of protein tyrosine phosphatases in vivo
Meng, T.-C., Fukada, T., & Tonks, N. K. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00445-8 · Cited by 1,040
Cited by
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269
“Nevertheless, some reports have suggested that decreases in plaque size and regression of atherosclerosis correlates with macrophages emigrating from the plaqu”
BackgroundCD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior
Silverstein, R. L., & Febbraio, M. (2009) · Science Signaling · doi:10.1126/scisignal.272re3 · Cited by 1,141
Self-citationMacrophage Phenotype and Function in Different Stages of Atherosclerosis
Tabas, I., & Bornfeldt, K. E. (2016) · Circulation Research · doi:10.1161/circresaha.115.306256 · Cited by 1,121
The immunology of atherosclerosis
Gisterå, A., & Hansson, G. K. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.51 · Cited by 982
Monocytes in atherosclerosis: subsets and functions
Woollard, K. J., & Geissmann, F. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.228 · Cited by 890
Miller, Y. I., Choi, S.-H., Wiesner, P., Fang, L., Harkewicz, R., Hartvigsen, K., Boullier, A., Gonen, A., Diehl, C. J., Que, X., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.223875 · Cited by 646
Regulation of macrophage immunometabolism in atherosclerosis
Koelwyn, G. J., Corr, E. M., Erbay, E., & Moore, K. J. (2018) · Nature Immunology · doi:10.1038/s41590-018-0113-3 · Cited by 555
Monocyte and Macrophage Dynamics During Atherogenesis
Ley, K., Miller, Y. I., & Hedrick, C. C. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.221127 · Cited by 554
CD36, a scavenger receptor implicated in atherosclerosis
Park, Y. M. (2014) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.38 · Cited by 517
Self-citationMetabolism of tissue macrophages in homeostasis and pathology
Wculek, S. K., Dunphy, G., Heras-Murillo, I., Mastrangelo, A., & Sancho, D. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00791-9 · Cited by 501
“Macrophage foam cells have a diminished migratory capacity, which reduces their ability to egress plaques [218, 219], an important contributor to potential atherosclerosis regression, and show increased expression of lipid handling genes [220].”
BackgroundOxidized LDL: Diversity, Patterns of Recognition, and Pathophysiology
Levitan, I., Volkov, S., & Subbaiah, P. V. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2733 · Cited by 473
Seimon, T. A., Nadolski, M. J., Liao, X., Magallon, J., Nguyen, M., Feric, N. T., Koschinsky, M. L., Harkewicz, R., Witztum, J. L., Tsimikas, S., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.09.010 · Cited by 457
CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate
Chen, Y., Zhang, J., Cui, W., & Silverstein, R. L. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20211314 · Cited by 454
Self-citationNew Insights into the Role of Inflammation in the Pathogenesis of Atherosclerosis
Wu, M.-Y., Li, C.-J., Hou, M.-F., & Chu, P.-Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102034 · Cited by 392
Redox control of inflammation in macrophages
Brüne, B., Dehne, N., Grossmann, N., Jung, M., Namgaladze, D., Schmid, T., von Knethen, A., & Weigert, A. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4785 · Cited by 377
van Gils, J. M., Derby, M. C., Fernandes, L. R., Ramkhelawon, B., Ray, T. D., Rayner, K. J., Parathath, S., Distel, E., Feig, J. L., Alvarez-Leite, J. I., et al. (2012) · Nature Immunology · doi:10.1038/ni.2205 · Cited by 365
Macrophage polarization and metabolism in atherosclerosis
Hou, P., Fang, J., Liu, Z., Shi, Y., Agostini, M., Bernassola, F., Bove, P., Candi, E., Rovella, V., Sica, G., et al. (2023) · Cell Death & Disease · doi:10.1038/s41419-023-06206-z · Cited by 350
Reactive oxygen species: key regulators in vascular health and diseases
Chen, Q., Wang, Q., Zhu, J., Xiao, Q., & Zhang, L. (2018) · British Journal of Pharmacology · doi:10.1111/bph.13828 · Cited by 338
The role of CD36 in cardiovascular disease
Shu, H., Peng, Y., Hang, W., Nie, J., Zhou, N., & Wang, D. W. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvaa319 · Cited by 277
Mitochondrial Metabolic Reprogramming by CD36 Signaling Drives Macrophage Inflammatory Responses
Chen, Y., Yang, M., Huang, W., Chen, W., Zhao, Y., Schulte, M. L., Volberding, P., Gerbec, Z., Zimmermann, M. T., Zeighami, A., et al. (2019) · Circulation Research · doi:10.1161/circresaha.119.315833 · Cited by 270
Self-citationModification of High Density Lipoprotein by Myeloperoxidase Generates a Pro-inflammatory Particle
Undurti, A., Huang, Y., Lupica, J. A., Smith, J. D., DiDonato, J. A., & Hazen, S. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047605 · Cited by 266
Phenotypic Polarization of Macrophages in Atherosclerosis
Leitinger, N., & Schulman, I. G. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300173 · Cited by 256
Role of macrophage scavenger receptors in atherosclerosis
Kzhyshkowska, J., Neyen, C., & Gordon, S. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.02.015 · Cited by 255
The central moTOR of metabolism
Simcox, J., & Lamming, D. W. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.02.024 · Cited by 174
(2010) · PubMed Central · Cited by 169
Chu, L.-Y., Ramakrishnan, D. P., & Silverstein, R. L. (2013) · Blood · doi:10.1182/blood-2013-01-482315 · Cited by 167
Self-citationDeletion of ABCA1 and ABCG1 Impairs Macrophage Migration Because of Increased Rac1 Signaling
Pagler, T. A., Wang, M., Mondal, M., Murphy, A. J., Westerterp, M., Moore, K. J., Maxfield, F. R., & Tall, A. R. (2011) · Circulation Research · doi:10.1161/circresaha.110.228619 · Cited by 105
Itabe, H. (2012) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.11-00020r1 · Cited by 87
Rizwan, H., Mohanta, J., Si, S., & Pal, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s141839 · Cited by 61
“28,29 Our previous findings demonstrated that cellular signaling pathways mediated by ROS/RNS in cellular compartments were associated with each other by elevated glucose in macrophages activation leading to apoptosis and inflammation, and these processes exacerbated atherogenesis.”
Metadata
- Authors
- Park, Y. M., Febbraio, M., & Silverstein, R. L.
- Venue
- Journal of Clinical Investigation
- Published
- 2008-12-08
- Volume
- 119
- Issue
- 1
- Pages
- 136-45
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2013899166
- Cited by
- 406
- References
- 53
- FWCI
- 9.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.